News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
767,347 Results
Type
Article (50783)
Company Profile (327)
Press Release (716220)
Multimedia
Podcasts (129)
Webinars (23)
Section
Business (212180)
Career Advice (2135)
Deals (36606)
Drug Delivery (149)
Drug Development (83553)
Employer Resources (177)
FDA (17196)
Job Trends (15788)
News (359458)
Policy (35206)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2870)
Academic (2)
Accelerated approval (45)
Adcomms (29)
Allergies (172)
Alliances (51755)
ALS (201)
Alzheimer's disease (1831)
Antibody-drug conjugate (ADC) (435)
Approvals (17527)
Artificial intelligence (668)
Autoimmune disease (250)
Automation (53)
Bankruptcy (370)
Best Places to Work (12259)
BIOSECURE Act (21)
Biosimilars (224)
Biotechnology (201)
Bladder cancer (182)
Brain cancer (71)
Breast cancer (724)
Cancer (5691)
Cardiovascular disease (472)
Career advice (1819)
Career pathing (43)
CAR-T (319)
CDC (69)
Celiac Disease (2)
Cell therapy (843)
Cervical cancer (45)
Clinical research (72018)
Collaboration (2072)
Company closure (5)
Compensation (1329)
Complete response letters (80)
COVID-19 (2925)
CRISPR (109)
C-suite (1093)
Cystic fibrosis (154)
Data (7506)
Decentralized trials (3)
Denatured (41)
Depression (168)
Dermatology (70)
Diabetes (581)
Diagnostics (7253)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (316)
Drug pricing (220)
Drug shortages (32)
Duchenne muscular dystrophy (280)
Earnings (92993)
Editorial (72)
Employer branding (22)
Employer resources (155)
Events (127624)
Executive appointments (1106)
FDA (20838)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1741)
Gene editing (231)
Generative AI (64)
Gene therapy (700)
GLP-1 (1097)
Government (5310)
Grass and pollen (7)
Guidances (403)
Healthcare (20470)
HIV (79)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (290)
Immuno-oncology (87)
Indications (167)
Infectious disease (3283)
Inflammatory bowel disease (212)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (281)
Interviews (337)
IPO (16995)
IRA (54)
Job creations (3867)
Job search strategy (1512)
JPM (69)
Kidney cancer (19)
Labor market (98)
Layoffs (585)
Leadership (39)
Legal (8513)
Liver cancer (103)
Longevity (32)
Lung cancer (755)
Lymphoma (418)
Machine learning (58)
Management (61)
Manufacturing (1003)
MASH (188)
Medical device (14554)
Medtech (14645)
Mergers & acquisitions (20832)
Metabolic disorders (1506)
mRNA (214)
Multiple sclerosis (184)
NASH (18)
Neurodegenerative disease (411)
Neuropsychiatric disorders (108)
Neuroscience (3323)
Neurotech (1)
NextGen: Class of 2026 (7129)
Non-profit (4960)
Now hiring (75)
Obesity (715)
Opinion (315)
Ovarian cancer (207)
Pain (250)
Pancreatic cancer (287)
Parkinson's disease (361)
Partnered (34)
Patents (571)
Patient recruitment (642)
Peanut (62)
People (62047)
Pharmaceutical (72)
Pharmacy benefit managers (35)
Phase 1 (22522)
Phase 2 (31566)
Phase 3 (23524)
Pipeline (7763)
Policy (345)
Postmarket research (2764)
Preclinical (9578)
Press Release (71)
Prostate cancer (290)
Psychedelics (58)
Radiopharmaceuticals (326)
Rare diseases (1064)
Real estate (6250)
Recruiting (71)
Regulatory (26687)
Reports (56)
Research institute (2625)
Resumes & cover letters (365)
Rett syndrome (34)
RNA editing (19)
RSV (94)
Schizophrenia (174)
Series A (292)
Series B (216)
Service/supplier (13)
Sickle cell disease (115)
Special edition (27)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3859)
State (2)
Stomach cancer (20)
Supply chain (133)
Tariffs (92)
The Weekly (86)
Vaccines (1183)
Venture capital (107)
Weight loss (468)
Women's health (124)
Worklife (21)
Date
Last 7 days (776)
Last 30 days (2742)
Last 365 days (31264)
2026 (10190)
2025 (31280)
2024 (36402)
2023 (41346)
2022 (52603)
2021 (57321)
2020 (56297)
2019 (49436)
2018 (37429)
2017 (33560)
2016 (33633)
2015 (39690)
2014 (33357)
2013 (28362)
2012 (30555)
2011 (31217)
2010 (29446)
Location
Africa (862)
Alabama (96)
Alaska (7)
Arizona (359)
Arkansas (15)
Asia (42330)
Australia (7046)
California (12904)
Canada (3673)
China (1315)
Colorado (557)
Connecticut (571)
Delaware (386)
Europe (92884)
Florida (1921)
Georgia (424)
Hawaii (4)
Idaho (68)
Illinois (1063)
India (90)
Indiana (599)
Iowa (24)
Japan (523)
Kansas (133)
Kentucky (50)
Louisiana (42)
Maine (87)
Maryland (1581)
Massachusetts (9295)
Michigan (378)
Minnesota (723)
Mississippi (6)
Missouri (149)
Montana (35)
Nebraska (29)
Nevada (142)
New Hampshire (90)
New Jersey (3462)
New Mexico (29)
New York (3425)
North Carolina (1704)
North Dakota (9)
Northern California (6385)
Ohio (398)
Oklahoma (25)
Oregon (43)
Pennsylvania (2586)
Puerto Rico (28)
Rhode Island (50)
South America (1229)
South Carolina (87)
South Dakota (2)
Southern California (5094)
Tennessee (205)
Texas (2057)
United States (46082)
Utah (389)
Vermont (1)
Virginia (314)
Washington D.C. (84)
Washington State (1050)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
767,347 Results for "lucira health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call
April 21, 2026
·
2 min read
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company’s Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder, PTSD, and traumatic brain injury
April 20, 2026
·
6 min read
Press Releases
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
March 23, 2026
·
5 min read
Press Releases
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
February 18, 2026
·
1 min read
Press Releases
Huxley Health Inc. Introduces Aerasyn Biotech Division, Expands Leadership and Scalable IP Platform, Engages Capital Partner for Up to $15M Financing and Prepares to Go Public Amid Growing U.S. Policy and Public Discourse on Psychedelics
April 20, 2026
·
8 min read
Press Releases
Randomized Controlled Trial Published in Urogynecology Demonstrates Leva® Pelvic Health System’s Efficacy in Treating Fecal Incontinence
April 17, 2026
·
6 min read
Press Releases
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
February 17, 2026
·
3 min read
Press Releases
BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
February 27, 2026
·
27 min read
Biotech Bay
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
Lucira Health, Inc. announced the launch of Lucira Connect, a new virtual care program that allows Lucira test users the ability to test, learn about treatment options, access a telehealth consultation, and if appropriate, receive a prescription all from home for only the $29 price of the test, excluding prescription costs.
November 17, 2022
·
5 min read
Press Releases
Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call
January 13, 2026
·
1 min read
1 of 76,735
Next
